BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 32977999)

  • 1. Genetic Lesions of Type I Interferon Signalling in Human Antiviral Immunity.
    Duncan CJA; Randall RE; Hambleton S
    Trends Genet; 2021 Jan; 37(1):46-58. PubMed ID: 32977999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The unique regulation and functions of type III interferons in antiviral immunity.
    Odendall C; Kagan JC
    Curr Opin Virol; 2015 Jun; 12():47-52. PubMed ID: 25771505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoding type I and III interferon signalling during viral infection.
    Mesev EV; LeDesma RA; Ploss A
    Nat Microbiol; 2019 Jun; 4(6):914-924. PubMed ID: 30936491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type III and Not Type I Interferons Efficiently Prevent the Spread of Rotavirus in Human Intestinal Epithelial Cells.
    Doldan P; Dai J; Metz-Zumaran C; Patton JT; Stanifer ML; Boulant S
    J Virol; 2022 Sep; 96(17):e0070622. PubMed ID: 36000839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudorabies Virus Inhibits Type I and Type III Interferon-Induced Signaling via Proteasomal Degradation of Janus Kinases.
    Yin Y; Romero N; Favoreel HW
    J Virol; 2021 Sep; 95(20):e0079321. PubMed ID: 34379505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Methyltransferase-Like Domain of Chikungunya Virus nsP2 Inhibits the Interferon Response by Promoting the Nuclear Export of STAT1.
    Göertz GP; McNally KL; Robertson SJ; Best SM; Pijlman GP; Fros JJ
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon signalling network in innate defence.
    Takaoka A; Yanai H
    Cell Microbiol; 2006 Jun; 8(6):907-22. PubMed ID: 16681834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral responses in mouse embryonic stem cells: differential development of cellular mechanisms in type I interferon production and response.
    Wang R; Wang J; Acharya D; Paul AM; Bai F; Huang F; Guo YL
    J Biol Chem; 2014 Sep; 289(36):25186-98. PubMed ID: 24966329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral tricks to grid-lock the type I interferon system.
    Versteeg GA; García-Sastre A
    Curr Opin Microbiol; 2010 Aug; 13(4):508-16. PubMed ID: 20538505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in anti-viral immune defence: revealing the importance of the IFN JAK/STAT pathway.
    Raftery N; Stevenson NJ
    Cell Mol Life Sci; 2017 Jul; 74(14):2525-2535. PubMed ID: 28432378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling.
    Crosse KM; Monson EA; Beard MR; Helbig KJ
    J Innate Immun; 2018; 10(2):85-93. PubMed ID: 29186718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNF26 temporally regulates virus-triggered type I interferon induction by two distinct mechanisms.
    Qin Y; Zhou MT; Hu MM; Hu YH; Zhang J; Guo L; Zhong B; Shu HB
    PLoS Pathog; 2014 Sep; 10(9):e1004358. PubMed ID: 25254379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance.
    Pervolaraki K; Rastgou Talemi S; Albrecht D; Bormann F; Bamford C; Mendoza JL; Garcia KC; McLauchlan J; Höfer T; Stanifer ML; Boulant S
    PLoS Pathog; 2018 Nov; 14(11):e1007420. PubMed ID: 30485383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I interferons and the innate immune response--more than just antiviral cytokines.
    Smith PL; Lombardi G; Foster GR
    Mol Immunol; 2005 May; 42(8):869-77. PubMed ID: 15829276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
    Ank N; West H; Bartholdy C; Eriksson K; Thomsen AR; Paludan SR
    J Virol; 2006 May; 80(9):4501-9. PubMed ID: 16611910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the distinct, intrinsic properties of the novel type I interferon, IFNϵ.
    Stifter SA; Matthews AY; Mangan NE; Fung KY; Drew A; Tate MD; Soares da Costa TP; Hampsey D; Mayall J; Hansbro PM; Garcia Minambres A; Eid SG; Mak J; Scoble J; Lovrecz G; deWeerd NA; Hertzog PJ
    J Biol Chem; 2018 Mar; 293(9):3168-3179. PubMed ID: 29187603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDA5 against enteric viruses through induction of interferon-like response partially via the JAK-STAT cascade.
    Li Y; Yu P; Qu C; Li P; Li Y; Ma Z; Wang W; de Man RA; Peppelenbosch MP; Pan Q
    Antiviral Res; 2020 Apr; 176():104743. PubMed ID: 32057771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells.
    Vareille M; Kieninger E; Alves MP; Kopf BS; Möller A; Geiser T; Johnston SL; Edwards MR; Regamey N
    Thorax; 2012 Jun; 67(6):517-25. PubMed ID: 22213737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCPIP1 is a positive regulator of type I interferons antiviral activity.
    Qian L; Zuo Y; Deng W; Miao Y; Liu J; Yuan Y; Guo T; Zhang L; Jin J; Wang J; Zheng H
    Biochem Biophys Res Commun; 2018 Apr; 498(4):891-897. PubMed ID: 29545178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.